This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Learn the scenarios where index funds tend to outperform actively managed funds and the factors that drive these outcomes.
14,988 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Moomoo launches a refreshed free stock promotion in March 2026, offering Nvidia shares worth up to $1,000 for new cus...
Oil prices climb as inflation concerns linger, prompting the Fed to hold rates steady for now. The impact rising fuel...
Hess Midstream’s capital return program is under review as a $60 million buyback coincides with a high payout ratio a...
Markets pivot as inflation remains above target and energy prices climb. One economist warns the next time moves it’l...
Coinbase stock stalls $200 after a 14% surge, with traders watching volume and regulatory headlines for the next move...
A quiet question from Rider Strong about shame hits the wallet hard: what if we stop caring about who we become? This...
Two quantum computing stocks with upside projections have caught the eye of Wall Street. This guide breaks down why t...
When personal space becomes a financial strategy, you gain control over housing, bills, and savings. This guide shows...
Walmart stock faces a balanced 2026–2030 path, with growth from e-commerce and membership services battling cost pres...
BlackRock’s chief executive argues that AI’s biggest impact is on who owns wealth, not just who loses a job. Here’s h...
Nuclear energy is attracting new attention from investors. This guide compares NuScale Power and Constellation Energy...